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Aim
To illustrate the anatomy of renal vasculature and its
variants on cross-sectional imaging.
To highlight the benefits of obtaining images in both
arterial and venous phase in staging and follow-up of
renal cancer.
Content
It is common practice to perform dual phase computed
tomography (CT) in preliminary staging and subsequent
follow-up of renal cancer patients in some institutions
across the United Kingdom. We provide the best examples
from our institution (2010-2013) with illustrations and the
clinical relevance for the conditions stated below.
Arterial phase
We discuss the normal anatomy and variants of the
renal artery including early division of artery, accessory
artery and double renal artery. In addition, usual and
uncommon sites (e.g. muscle, small bowel, pancreas) of
hypervascular metastasis in primary renal cancer
patients will be illustrated.
Portal-venous phase
We will highlight the normal anatomy and variants of the
renal vein (e.g. aberrant, accessory renal veins) and asso-
ciated tumour infiltration in unexpected veins (e.g. portal
vein, gonadal vein) and solid organ metastasis.
Conclusion
The renal vasculature is frequently visualised on imaging
but often overlooked. This exhibit will provide radiology
trainee’s an insight into the anatomical variants and its
relevance in management of primary renal cancer. It
reminds them of the common and uncommon metastasise
and tumour infiltration seen in renal cancer, thus affecting
the outcome.
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